电生理设备市场规模、份额、成长分析（按类型、适应症、应用、最终用户、地区）- 2025 年至 2032 年产业预测

2023 年电生理设备市场规模价值 68 亿美元，预计将从 2024 年的 74.4 亿美元成长到 2032 年的 152.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.4%。

电生理学 (EP) 市场正在经历显着增长，这得益于心房颤动 (AF) 等心臟疾病的盛行率不断上升以及对先进心臟监测设备的需求。造成此现象的因素包括千禧世代不健康的生活方式，美国疾病管制与预防中心预测，到2031年，约有1,210万美国将罹患心房颤动。欧洲人尤其容易罹患心房颤动，心臟麻痹是西方国家最大的死亡原因。行动心臟监测技术的进步将进一步推动这一市场的发展，例如透过无线技术对植入设备进行远端追踪和数据管理，从而增强对重要患者资讯的存取。以最近 FDA 的核准为代表的微创手术和创新技术的趋势凸显了该领域的光明前景，因为医疗保健提供者采用 EP 设备来更好地管理心律不整。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

电生理设备市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• 消融导管
• 诊断导管
• 地图系统
• 配件
• 其他的

电生理设备市场规模（依适应症及复合年增长率）（2025-2032）

• 市场概览
• 心房颤动（AF）
• 房室结迴旋性心搏过速（AVNRT）
• 心室上性心搏过速
• 心搏过缓
• 沃尔夫-巴金森-怀特氏症候群（WPW）
• 其他的

电生理设备市场规模（依应用和复合年增长率）（2025-2032）

• 市场概览
• 诊断设备
  • 诊断电生理导管
  • 连续型心电图监测装置
  • EP 映射与成像系统
  • 心电图（ECG）
  • 可植入心臟监视器 (ICM)
  • 其他的
• 治疗设备
  • 自动体外电击器（AED）
  • 植入式心臟整流去颤器（ICD）
  • CRT-D
  • CRT-P
  • 导管
  • 起搏器
  • 其他的

电生理设备市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 门诊手术中心
• 其他的

电生理设备市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Koninklijke Philips NV（Netherlands）
• MicroPort Scientific Corporation（China）
• Nihon Kohden Corporation（Japan）
• Stereotaxis, Inc.（USA）
• Biosense Webster, Inc.（USA）
• Biotronik SE & Co. KG（Germany）
• CardioFocus, Inc.（USA）
• CathVision ApS（Denmark）
• Japan Lifeline Co., Ltd.（Japan）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Osypka AG（Germany）
• Pentax Medical（Japan）
• Shanghai MicroPort EP MedTech Co., Ltd.（China）
• Teleflex Incorporated（USA）
• Topera, Inc.（USA）

结论和建议

Electrophysiology Devices Market size was valued at USD 6.8 billion in 2023 and is poised to grow from USD 7.44 billion in 2024 to USD 15.26 billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).

The electrophysiology (EP) market is experiencing significant growth driven by the rising prevalence of heart diseases like atrial fibrillation (AF) and the demand for advanced cardiac monitoring equipment. Contributing factors include unhealthy lifestyle choices among millennials, with predictions from the CDC estimating approximately 12.1 million Americans affected by AF by 2031. Notably, Europeans exhibit a higher susceptibility to AF, with sudden cardiac arrest being a leading cause of death in Western nations. The market is further fueled by advancements in mobile cardiac monitoring, including remote tracking of implanted devices and data management through wireless technology, enhancing access to critical patient information. The trend towards minimally invasive procedures and innovative technologies, exemplified by recent FDA approvals, underscores the sector's promising outlook as healthcare providers adopt EP devices for better arrhythmia management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Electrophysiology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Electrophysiology Devices Market Segments Analysis

Global Electrophysiology Devices Market is segmented by Type, Indication, Application, End-user and region. Based on Type, the market is segmented into Ablation Catheters, Diagnostic Catheters, Mapping System, Accessories and Others. Based on Indication, the market is segmented into Atrial Fibrillation (AF), Atrioventricular Nodal Re-entry Tachycardia (AVNRT), Supraventricular Tachycardia, Bradycardia, Wolff-Parkinson-White Syndrome (WPW) and Others. Based on Application, the market is segmented into Diagnostic Devices and Treatment Devices. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Electrophysiology Devices Market

The increasing incidence of cardiac arrhythmias, particularly atrial fibrillation and ventricular tachycardia, significantly propels the electrophysiology devices market. As these heart conditions become more common, the demand for precise diagnostic and therapeutic solutions rises. Electrophysiology devices play a crucial role in managing these disorders by providing essential tools for both accurate assessment and effective treatment options. The need to address the complications associated with arrhythmias is driving innovation and investment in this market, leading to advancements in device technology and enhanced patient care. Consequently, the ongoing rise in arrhythmia cases is a key impetus behind the growth of this sector.

Restraints in the Electrophysiology Devices Market

The Electrophysiology Devices market faces significant constraints due to the high costs associated with these advanced technologies. This financial barrier can hinder their widespread adoption, particularly in areas with constrained healthcare budgets or within healthcare systems that enforce strict reimbursement policies. A considerable upfront investment is required for these devices, making them less accessible to healthcare providers in economically challenged regions. Consequently, the elevated price tag acts as a critical restraint on market growth, limiting the ability to integrate these essential tools into clinical practice, thereby impacting patient care and treatment outcomes in various healthcare settings.

Market Trends of the Electrophysiology Devices Market

The electrophysiology devices market is increasingly favoring minimally invasive procedures, driven by technological advancements and innovative device designs. These catheter-based techniques facilitate accurate diagnosis and treatment of cardiac arrhythmias with significantly improved patient outcomes, including reduced discomfort, shorter recovery periods, and lower complication rates. As healthcare providers and patients alike prioritize less invasive interventions, the demand for electrophysiology devices that support these methods is poised for substantial growth. This trend not only enhances procedural efficiency but also aligns with the broader shift towards patient-centered care in the medical field, indicating a promising future for this segment of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Electrophysiology Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Ablation Catheters
• Diagnostic Catheters
• Mapping System
• Accessories
• Others

Global Electrophysiology Devices Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Atrial Fibrillation (AF)
• Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
• Supraventricular Tachycardia
• Bradycardia
• Wolff-Parkinson-White Syndrome (WPW)
• Others

Global Electrophysiology Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostic Devices
  • Diagnostic Electrophysiology Catheters
  • Holter Monitoring Devices
  • EP Mapping & Imaging Systems
  • Electrocardiograph (ECG)
  • Insertable Cardiac Monitors (ICM)
  • Others
• Treatment Devices
  • Automated external defibrillators (AEDs)
  • Implantable Cardioverter Defibrillators (ICDs)
  • CRT-D
  • CRT-P
  • Catheters
  • Pacemakers
  • Others

Global Electrophysiology Devices Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory surgical centers
• Others

Global Electrophysiology Devices Market Size & CAGR (2025-2032)

• North America (Type, Indication, Application, End-user)
  • US
  • Canada
• Europe (Type, Indication, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stereotaxis, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosense Webster, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioFocus, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathVision ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Lifeline Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pentax Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai MicroPort EP MedTech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations